HYPERURICEMIA AND POTENTIAL RISK OF CARDIOVASCULAR AND RENAL DISEASES

Besides the well accepted need to treat hyperuricemia associated with gout, some large observational studies and small prospective therapeutic trials have suggested that treating asymptomatic hyperuricemia, especially by xanthine oxidase inhibition, the enzyme producing uric acid, could be beneficia...

Full description

Saved in:
Bibliographic Details
Published inRevue médicale de Liège Vol. 71; no. 5; p. 262
Main Authors Schils, R, Krzesinski, J M
Format Journal Article
LanguageFrench
Published Belgium 01.05.2016
Subjects
Aged
Cardiovascular Diseases - etiology
Cardiovascular Diseases - prevention & control
Gout - complications
Gout - drug therapy
Gout Suppressants - therapeutic use
Humans
Hyperuricemia - complications
Hyperuricemia - drug therapy
Hyperuricemia - metabolism
Kidney Diseases - etiology
Kidney Diseases - therapy
Male
Risk Factors
Uric Acid - metabolism
Online AccessGet more information

Cover

More Information
Summary:Besides the well accepted need to treat hyperuricemia associated with gout, some large observational studies and small prospective therapeutic trials have suggested that treating asymptomatic hyperuricemia, especially by xanthine oxidase inhibition, the enzyme producing uric acid, could be beneficial for cardiovascular and renal risk prevention. This article discusses the literature about this promising approach, which, however, requests prospective validation.
ISSN:0370-629X